Global Health Clinics (MJRX.X) AI Stock Analysis

• Market Cap: C$78.27K
• Dividend Yield: N/A
• Average Volume (3M): 16.00
• Price to Earnings (P/E): ―
• Beta (1Y): -0.84
• Revenue Growth: -78.90%
• EPS Growth: -9.28%
• Country: CA
• Employees: 8
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.15
• Shares Outstanding: 1,043,568
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 16
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.02
• Price to Sales (P/S): 1.97
• P/FCF Ratio: -0.16
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: C$0.04 ▼(-2.50% Downside)
• Action: Reiterated
• Date: 08/24/26

Positive Factors

Losses Have Moderated

Lower losses than in 2021 may indicate some reduction in the scale of deterioration. However, this is only a relative improvement because revenue is shrinking, gross profit remains negative, and the company is still materially unprofitable.

Negative Factors

Shrinking Revenue

Persistent revenue contraction signals weakening demand, distribution, or product traction and reduces the scale available to absorb fixed costs. Continued declines would make a return to sustainable profitability more difficult over the next several months.

Global Health Clinics Business Overview & Revenue Model

Company Description

Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated fo...

Read more

Operating within the cannabis industry, Global Health Clinics Ltd. manages medical facilities that provide guidance to patients seeking to legally obtain and use marijuana. The company is also involved in creating psilocybin products designated fo...

Global Health Clinics Financial Statement Overview

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Global Health Clinics Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.04
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MJRX.X, the sentiment is Positive. The current price of 0.04 is below the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.27, and below the 200-day MA of 0.37, indicating a bullish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 78.98 is Negative, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:MJRX.X.

Global Health Clinics Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GTII	65 Neutral	C$2.26B	13.39	6.82%	―	3.81%	344.13%
DHT.UN	63 Neutral	C$929.60M	-15.26	-10.07%	3.54%	6.33%	-1216.48%
CURA	53 Neutral	C$3.72B	-73.76	-4.47%	―	1.50%	81.84%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VRNO	51 Neutral	C$2.17B	-1.68	-35.22%	―	-2.30%	26.63%
MJRX.X	43 Neutral	C$78.27K	-0.28	28.54%	―	-78.90%	-9.28%

Global Health Clinics Corporate Events